Clinical Trials Logo

Clinical Trial Summary

To assess the effect of treatment with Glycopyronnium (GP) MDI administered twice daily (BID) and Formoterol Fumarate (FF) MDI administered BID on specific image-based airway volumes and resistance in subjects with moderate to severe chronic obstructive pulmonary disease (COPD) following chronic dosing after approximately two weeks treatment.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02937584
Study type Interventional
Source Pearl Therapeutics, Inc.
Contact
Status Completed
Phase Phase 3
Start date December 29, 2016
Completion date May 28, 2018

See also
  Status Clinical Trial Phase
Not yet recruiting NCT05016466 - GOLD 0 - DLCO 1: A Look Beyond the Obstruction. Is Spirometry Enough for COPD (Chronic Obstructive Pulmonary Disease) Screening?
Not yet recruiting NCT05114434 - Effect of BDP/Formoterol/G on Cough Efficacy in Moderate to Severe COPD Patients (EFFICACE)
Recruiting NCT05297279 - OMEGA - Dietary Intervention - COPD Trial N/A
Active, not recruiting NCT03658538 - Motivational Interviewing and Air Cleaners for Smokers With COPD (MOVE COPD) N/A
Not yet recruiting NCT04820257 - Home-based Pulmonary Rehabilitation for COPD Patients N/A